Goldman Sachs Research Summary (JAN 19, 2007)
This morning, Goldman Sachs started 3M (MMM) and International Paper (IP) with Neutral ratings. Rite Aid (RAD) was downgraded from a Neutral to Sell rating after the recent stock gains. As a reminder, this was Cramer’s #2 speculative play for…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This morning, Goldman Sachs started 3M (MMM) and International Paper (IP) with Neutral ratings.
Rite Aid (RAD) was downgraded from a Neutral to Sell rating after the recent stock gains. As a reminder, this was Cramer’s #2 speculative play for 2007. Goldman trimmed the current fiscal estimates from $0.07 to $0.03. This was added to Goldman’s Americas Investment SELL List.
TRW Automotive (TRW) was also downgraded from a Neutral rating down to a Sell rating. This was added to Goldman’s Americas Investment SELL List.
JDSU (JDSU) estimates were raised from $0.21 EPS up to $0.26 EPS for the current year; this after the company raised guidance last night.
Knight Capital Group (NITE) saw its estimates trimmed at Goldman Sachs from $1.32 EPS down to $1.15 for the current year and the coming year estimates were trimmed from $1.45 to $1.26.
Xilinx (XLNX) estimates were also trimmed after the company lowered guidance; Goldman cut next fiscal year from $1.22 EPS to $1.10.
Goldman Sachs also reiterated a BUY rating on J&J (JNJ) and said it sees 11% upside to its 6-month target of $75.00. This replaces Stryker (SYK) on the Americas Conviction Buy List.
Contact [email protected] for any questions or corrections.
